Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Hepatitis Diagnostic Tests Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Market Overview:

The global hepatitis diagnostic tests market size reached US$ 5.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 7.5 Billion by 2028, exhibiting a growth rate (CAGR) of 5.1% during 2023-2028.

Hepatitis represents a major global health threat that requires an urgent response. According to estimates, hepatitis causes 1.3 Million-1.5 Million deaths each year, a figure that is comparable to the deaths caused by tuberculosis and even higher than those caused by HIV. Moreover, while mortality from diseases such as HIV, tuberculosis, and malaria are now declining, mortality from hepatitis has been rising. According to estimates around 325-350 Million people across the globe are carriers of hepatitis B or C virus infections, which may remain asymptomatic for decades. Moreover, every year, around 1.75 Million people get infected by the hepatitis C virus infection. Unless these people receive timely testing and treatment, they are at risk of severe liver disease and even death. Diagnostic tests help in the early detection of hepatitis infections and increase the chances of survival of the patient by correct medication and treatment.

 

 
 

www.imarcgroup.com

Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

The global demand of hepatitis diagnostic tests is currently exhibiting strong growth. This market is currently being catalyzed by a number of factors such as the increasing burden of hepatitis across the globe, rising number of blood transfusions and donations, technological advancements and the advantages offered by PoC (Point of Care) test, and rising awareness levels. A major trend being witnessed in this market has been a shift from conventional testing methods to molecular diagnostics. This has resulted in an increased accuracy and reduced the total time required to get the results.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global hepatitis diagnostic tests market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on test type.

Breakup by Test Type:

 

 
 

www.imarcgroup.com

Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

  • Blood Tests
  • Imaging Test
  • Liver Biopsy
     

Based on the test type, the market has been segmented into blood tests, imaging test and liver biopsy. Blood tests currently represent the biggest application. Blood tests are further segmented into liver function test, immunoassays, and nucleic acid tests.

Breakup by Region:

 

 
 

www.imarcgroup.com

To get more information on the regional analysis of this market, Request Sample

  • North America
  • Asia Pacific
  • Europe
  • Middle East and Africa
  • Latin America
     

Region-wise, the market has been segmented into North America, Asia Pacific, Europe, Middle East and Africa and Latin America. Amongst these, North America is the biggest market, accounting for the majority of the global market.

Competitive Landscape:

The competitive landscape of the market has also been examined with some of the key players being Siemens AG, Abbott Laboratories, MedMira Inc, Qiagen GmbH, Beckman Coulter Inc (Danaher Corporation), F. Hoffmann- La Roche AG, Diasorin S.p.A, bioMeriuex SA, Hologic Inc., and Bio-Rad Laboratories Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2022
 Historical Period 2017-2022
Forecast Period 2023-2028
Units US$ Billion
Segment Coverage Test Type, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Companies Covered Siemens AG, Abbott Laboratories, MedMira Inc, Qiagen GmbH, Beckman Coulter Inc (Danaher Corporation), F. Hoffmann- La Roche AG, Diasorin S.p.A, bioMeriuex SA, Hologic Inc., and Bio-Rad Laboratories Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Hepatitis Diagnostic Tests Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Breakup by Test Type
    5.5    Market Breakup by Region
    5.6    Market Forecast
    5.7    SWOT Analysis
        5.7.1    Overview
        5.7.2    Strengths
        5.7.3    Weaknesses
        5.7.4    Opportunities
        5.7.5    Threats
    5.8    Value Chain Analysis
    5.9    Porters Five Forces Analysis
        5.9.1    Overview
        5.9.2    Bargaining Power of Buyers
        5.9.3    Bargaining Power of Suppliers
        5.9.4    Degree of Competition
        5.9.5    Threat of New Entrants
        5.9.6    Threat of Substitutes
    5.10    Price Analysis
6   Market Breakup by Test Type
    6.1    Blood Tests
        6.1.1     Market Trends
        6.1.2    Market Forecast
    6.2    Imaging Test
        6.2.1    Market Trends
        6.2.2    Market Forecast
    6.3    Liver Biopsy
        6.3.1    Market Trends
        6.3.2    Market Forecast
7   Market Breakup by Region
    7.1    North America
        7.1.1    Market Trends
        7.1.2    Market Forecast
    7.2    Asia Pacific
        7.2.1    Market Trends
        7.2.2    Market Forecast
    7.3    Europe
        7.3.1    Market Trends
        7.3.2    Market Forecast
    7.4    Middle East and Africa
        7.4.1    Market Trends
        7.4.2    Market Forecast
    7.5    Latin America
        7.5.1    Market Trends
        7.5.2    Market Forecast
8   Competitive Landscape
    8.1    Market Structure
    8.2    Key Players
    8.3    Profiles of Key Players
        8.3.1    Siemens AG 
        8.3.2    Abbott Laboratories 
        8.3.3    MedMira Inc 
        8.3.4    Qiagen GmbH
        8.3.5    Beckman Coulter Inc (Danaher Corporation) 
        8.3.6    F. Hoffmann- La Roche AG
        8.3.7    Diasorin S.p.A
        8.3.8    bioMeriuex SA
        8.3.9    Hologic Inc 
        8.3.10  Bio-Rad Laboratories Inc

List of Figures

Figure 1: Global: Hepatitis Diagnostic Tests Market: Major Drivers and Challenges
Figure 2: Global: Hepatitis Diagnostic Tests Market: Sales Value (in Billion US$), 2017 - 2022
Figure 3: Global: Hepatitis Diagnostic Tests Market: Breakup by Test Type (in %), 2022
Figure 4: Global: Hepatitis Diagnostic Tests Market: Breakup by Region (in %), 2022
Figure 5: Global: Hepatitis Diagnostic Tests Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 6: Global: Hepatitis Diagnostic Tests Industry: SWOT Analysis
Figure 7: Global: Hepatitis Diagnostic Tests Industry: Value Chain Analysis
Figure 8: Global: Hepatitis Diagnostic Tests Industry: Porter’s Five Forces Analysis
Figure 9: Global: Hepatitis Diagnostic Tests (Blood Test) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Hepatitis Diagnostic Tests (Blood Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Hepatitis Diagnostic Tests (Imaging Test) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Hepatitis Diagnostic Tests (Imaging Test) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Hepatitis Diagnostic Tests (Liver Biopsy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Hepatitis Diagnostic Tests (Liver Biopsy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: North America: Hepatitis Diagnostic Tests Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: North America: Hepatitis Diagnostic Tests Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Asia Pacific: Hepatitis Diagnostic Tests Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Asia Pacific: Hepatitis Diagnostic Tests Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Europe: Hepatitis Diagnostic Tests Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Europe: Hepatitis Diagnostic Tests Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Middle East and Africa: Hepatitis Diagnostic Tests Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Middle East and Africa: Hepatitis Diagnostic Tests Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Latin America: Hepatitis Diagnostic Tests Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Latin America: Hepatitis Diagnostic Tests Market Forecast: Sales Value (in Million US$), 2023-2028

List of Tables

Table 1: Global: Hepatitis Diagnostic Tests Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Hepatitis Diagnostic Tests Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
Table 3: Global: Hepatitis Diagnostic Tests Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 4: Global: Hepatitis Diagnostic Tests Market: Competitive Structure
Table 5: Global: Hepatitis Diagnostic Tests Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Questions Answered in This Report

The global hepatitis diagnostic tests market was valued at US$ 5.6 Billion in 2022.

We expect the global hepatitis diagnostic tests market to exhibit a CAGR of 5.1% during 2023-2028.

The rising prevalence of hepatitis, along with the growing demand for hepatitis diagnostic tests for early detection of hepatitis A, B, or C infections, is primarily driving the global hepatitis diagnostic tests market.

The sudden outbreak of the COVID-19 pandemic had led to the postponement of elective hepatitis treatments to reduce the risk of the coronavirus infection upon hospital visits or interaction with medical equipment, thereby negatively impacting the global market for hepatitis diagnostic tests.

Based on the test type, the global hepatitis diagnostic tests market can be bifurcated into blood tests, imaging test, and liver biopsy. Currently, blood tests exhibit a clear dominance in the market.

On a regional level, the market has been classified into North America, Asia Pacific, Europe, Middle East and Africa, and Latin America, where North America currently dominates the global market.

Some of the major players in the global hepatitis diagnostic tests market include Siemens AG, Abbott Laboratories, MedMira Inc, Qiagen GmbH, Beckman Coulter Inc (Danaher Corporation), F. Hoffmann- La Roche AG, Diasorin S.p.A, bioMeriuex SA, Hologic Inc., and Bio-Rad Laboratories Inc.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links

4